Cellular Activation Triggered by the Autosomal Dominant Polycystic Kidney Disease Gene Product PKD2

REFERENCES

• Arnould, T., E. Kim, L. Tsiokas, F. Jochimsen, W. Gruning, J. D. Chang, and J. Walz 1998. The polycystic kidney disease 1 gene product mediates protein kinase C alpha-dependent and c-Jun N-terminal kinase-dependent activation of the transcription factor AP-1. J. Biol. Chem. 273:6013–6018.
   PubMed Web of Science ®Google Scholar
• Bagrodia, S., B. Derijard, R. J. Davis, and J. Cerione 1995. Cdc42 and PAK-mediated signaling leads to Jun kinase and p38 mitogen-activated protein kinase activation. J. Biol. Chem. 270:27995–27998.
   PubMed Web of Science ®Google Scholar
• Boyle, W. J., T. Smeal, L. H. Defize, P. Angel, J. R. Woodgett, M. Karin, and J. Hunter 1991. Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity. Cell 64:573–584.
   PubMed Web of Science ®Google Scholar
• Chen, Y., A. Takeshita, K. Ozaki, S. Kitano, and J. Hanazawa 1996. Transcriptional regulation by transforming growth factor beta of the expression of retinoic acid and retinoid X receptor genes in osteoblastic cells is mediated through AP-1. J. Biol. Chem. 271:31602–31606.
   PubMedGoogle Scholar
• Coso, O. A., M. Chiariello, J. C. Yu, H. Teramoto, P. Crespo, N. Xu, T. Miki, and J. Gutkind 1995. The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell 81:1137–1146.
   PubMed Web of Science ®Google Scholar
• Cowley, B. D. Jr., L. J. Chadwick, J. J. Grantham, and J. Calvet 1991. Elevated proto-oncogene expression in polycystic kidneys of the C57BL/6J (cpk) mouse. J. Am. Soc. Nephrol. 1:1048–1053.
   PubMed Web of Science ®Google Scholar
• Daoust, M. C., D. M. Reynolds, D. G. Bichet, and J. Somlo 1995. Evidence for a third genetic locus for autosomal dominant polycystic kidney disease. Genomics 2535:733–736.
   Google Scholar
• Decock, J. B., J. Gillespie-Brown, P. J. Parker, P. H. Sugden, and J. Fuller 1994. Classical, novel and atypical isoforms of PKC stimulate ANF- and TRE/AP-1-regulated-promoter activity in ventricular cardiomyocytes. FEBS Lett. 356:275–278.
   PubMedGoogle Scholar
• Derijard, B., M. Hibi, I. H. Wu, T. Barrett, B. Su, T. Deng, M. Karin, and J. Davis 1994. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76:1025–1037.
   PubMed Web of Science ®Google Scholar
• Derijard, B., J. Raingeaud, T. Barrett, I. H. Wu, J. Han, R. J. Ulevitch, and J. Davis 1995. Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms. Science 267:682–685.
   PubMed Web of Science ®Google Scholar
• Dong, Z., R. H. Xu, J. Kim, S. N. Zhan, W. Y. Ma, N. H. Colburn, and J. Kung 1996. AP-1/jun is required for early Xenopus development and mediates mesoderm induction by fibroblast growth factor but not by activin. J. Biol. Chem. 271:9942–9946.
   PubMedGoogle Scholar
• The European Polycystic Kidney Disease Consortium. 1994. The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. Cell 77:881–894.
   PubMedGoogle Scholar
• Fishman, D. D., S. Segal, and J. Livneh 1998. The role of protein kinase C in G1 and G2/M phases of the cell cycle. Int. J. Oncol. 12:181–186.
   PubMed Web of Science ®Google Scholar
• Frey, M. R., M. L. Saxon, X. Zhao, A. Rollins, S. S. Evans, and J. Black 1997. Protein kinase C isozyme-mediated cell cycle arrest involves induction of p21(waf1/cip1) and p27(kip1) and hypophosphorylation of the retinoblastoma protein in intestinal epithelial cells. J. Biol. Chem. 272:9424–9435.
   PubMed Web of Science ®Google Scholar
• Genot, E. M., P. J. Parker, and J. Cantrell 1995. Analysis of the role of protein kinase C-alpha, -epsilon, and -zeta in T cell activation. J. Biol. Chem. 270:9833–9839.
   PubMedGoogle Scholar
• Grantham, J. J. 1983. Polycystic kidney disease: a predominance of giant nephrons. Am. J. Physiol. 244:F3–F10.
   PubMed Web of Science ®Google Scholar
• Harding, M. A., V. H. Gattone II, J. J. Grantham, and J. Calvet 1992. Localization of overexpressed c-myc mRNA in polycystic kidneys of the cpk mouse. Kidney Int. 41:317–325.
   PubMedGoogle Scholar
• Hibi, M., A. Lin, T. Smeal, A. Minden, and J. Karin 1993. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev. 7:2135–2148.
   PubMed Web of Science ®Google Scholar
• Huang, T. S., S. C. Lee, and J. Lin 1991. Suppression of c-Jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells. Proc. Natl. Acad. Sci. USA 88:5292–5296.
   PubMed Web of Science ®Google Scholar
• Hughes, J., C. J. Ward, B. Peral, R. Aspinwall, K. Clark, J. L. San Millan, V. Gamble, and J. Harris 1995. The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat. Genet. 10:151–160.
   PubMed Web of Science ®Google Scholar
• The International Polycystic Kidney Disease Consortium. 1995. Polycystic kidney disease: the complete structure of the PKD1 gene and its protein. Cell 81:289–298.
   PubMedGoogle Scholar
• Jiang, Y., C. Chen, Z. Li, W. Guo, J. A. Gegner, S. Lin, and J. Han 1996. Characterization of the structure and function of a new mitogen-activated protein kinase (p38beta). J. Biol. Chem. 271:17920–17926.
   PubMed Web of Science ®Google Scholar
• Jiang, Y., H. Gram, M. Zhao, L. New, J. Gu, L. Feng, F. Di Padova, R. J. Ulevitch, and J. Han 1997. Characterization of the structure and function of the fourth member of p38 group mitogen-activated protein kinases, p38delta. J. Biol. Chem. 272:30122–30128.
   PubMed Web of Science ®Google Scholar
• Johnson, R. S., B. van Lingen, V. E. Papaioannou, and J. Spiegelman 1993. A null mutation at the c-jun locus causes embryonic lethality and retarded cell growth in culture. Genes Dev. 7:1309–1317.
   PubMed Web of Science ®Google Scholar
• Just, I., M. Wilm, J. Selzer, G. Rex, C. von Eichel-Streiber, M. Mann, and J. Aktories 1995. The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins. J. Biol. Chem. 270:13932–13936.
   PubMed Web of Science ®Google Scholar
• Karin, M., Z. Liu, and J. Zandi 1997. AP-1 function and regulation. Curr. Opin. Cell Biol. 9:240–246.
   PubMed Web of Science ®Google Scholar
• Kimberling, W. J., S. Kumar, P. A. Gabow, J. B. Kenyon, C. J. Connolly, and J. Somlo 1993. Autosomal dominant polycystic kidney disease: localization of the second gene to chromosome 4q13-q23. Genomics 18:467–472.
   PubMed Web of Science ®Google Scholar
• Lanoix, J., V. D’Agati, M. Szabolcs, and J. Trudel 1996. Dysregulation of cellular proliferation and apoptosis mediates human autosomal dominant polycystic kidney disease (ADPKD). Oncogene 13:1153–1160.
   PubMedGoogle Scholar
• Lavoie, J. N., G. L’Allemain, A. Brunet, R. Muller, and J. Pouyssegur 1996. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J. Biol. Chem. 271:20608–20616.
   PubMed Web of Science ®Google Scholar
• Lu, W., and J. Zhou 1997. Perinatal lethality with kidney and pancreas defects in mice with a targeted Pkd1 mutation. Nat. Genet. 17:179–181.
   PubMed Web of Science ®Google Scholar
• Marshall, C. J. 1995. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179–185.
   PubMed Web of Science ®Google Scholar
• Mihalik, R., G. Farkas, L. Kopper, M. Benczur, and J. Farago 1996. Possible involvement of protein kinase C-epsilon in phorbol ester-induced growth inhibition of human lymphoblastic cells. Int. J. Biochem. Cell Biol. 28:925–933.
   PubMedGoogle Scholar
• Minden, A., A. Lin, F. X. Claret, A. Abo, and J. Karin 1995. Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell 81:1147–1157.
   PubMed Web of Science ®Google Scholar
• Minden, A., A. Lin, T. Smeal, B. Dérijard, M. Cobb, R. Davis, and J. Karin 1994. c-Jun N-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen-activated protein kinases. Mol. Cell. Biol. 14:6683–6688.
   PubMedGoogle Scholar
• Mochizuki, T., G. Wu, T. Hayashi, S. L. Xenophontos, B. Veldhuisen, J. J. Saris, D. M. Reynolds, Y. Cai, P. A. Gavow, A. Pierides, W. J. Kimberling, M. H. Breuning, C. C. Deltas, D. J. Peters, and J. Somlo 1996. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 272:1339–1342.
   PubMed Web of Science ®Google Scholar
• Molnar, A., A. M. Theodoras, L. I. Zon, and J. Kyriakis 1997. Cdc42Hs, but not Rac1, inhibits serum-stimulated cell cycle progression at G1/S through a mechanism requiring p38/RK. J. Biol. Chem. 272:13229–13235.
   PubMed Web of Science ®Google Scholar
• Moriya, S., A. Kazlauskas, K. Akimoto, S. Hirai, K. Mizuno, T. Takenawa, Y. Fukui, Y. Watanabe, S. Ozaki, and J. Ohno 1996. Platelet-derived growth factor activates protein kinase C epsilon through redundant and independent signaling pathways involving phospholipase C gamma or phosphatidylinositol 3-kinase. Proc. Natl. Acad. Sci. USA 93:151–155.
   PubMed Web of Science ®Google Scholar
• Musial, A., A. Mandal, E. Coroneos, and J. Kester 1995. Interleukin-1 and endothelin stimulate distinct species of diglycerides that differentially regulate protein kinase C in mesangial cells. J. Biol. Chem. 270:21632–21638.
   PubMed Web of Science ®Google Scholar
• Narumiya, S. 1996. The small GTPase Rho: cellular functions and signal transduction. J. Biochem. 120:215–228.
   PubMed Web of Science ®Google Scholar
• Ostlund, E., C. F. Mendez, G. Jacobsson, J. Fryckstedt, B. Meister, and J. Aperia 1995. Expression of protein kinase C isoforms in renal tissue. Kidney Int. 47:766–773.
   PubMedGoogle Scholar
• Qian, F., F. J. Germino, Y. Cai, X. Zhang, S. Somlo, and J. Germino 1997. PKD1 interacts with PKD2 through a probable coiled-coil domain. Nat. Genet. 16:179–183.
   PubMed Web of Science ®Google Scholar
• Raingeaud, J., S. Gupta, J. S. Rogers, M. Dickens, J. Han, R. J. Ulevitch, and J. Davis 1995. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem. 270:7420–7426.
   PubMed Web of Science ®Google Scholar
• Reeders, S. T., M. H. Breuning, K. E. Davies, R. D. Nicholls, A. P. Jarman, D. R. Higgs, P. L. Pearson, and J. Weatherall 1985. A highly polymorphic DNA marker linked to adult polycystic kidney disease on chromosome 16. Nature 317:542–544.
   PubMed Web of Science ®Google Scholar
• Riesgo-Escovar, J. R., and J. Hafen 1997. Common and distinct roles of DFos and DJun during Drosophila development. Science 278:669–672.
   PubMedGoogle Scholar
• Sandford, R., B. Sgotto, S. Aparicio, S. Brenner, M. Vaudin, R. K. Wilson, S. Chissoe, K. Pepin, A. Bateman, C. Chothia, J. Hughes, and J. Harris 1997. Comparative analysis of the polycystic kidney disease 1 (PKD1) gene reveals an integral membrane glycoprotein with multiple evolutionary conserved domains. Hum. Mol. Genet. 6:1483–1489.
   PubMedGoogle Scholar
• Sasaguri, T., C. Kosaka, M. Hirata, J. Masuda, K. Shimokado, M. Fujishima, and J. Ogata 1993. Protein kinase C-mediated inhibition of vascular smooth muscle cell proliferation: the isoforms that may mediate G1/S inhibition. Exp. Cell Res. 208:311–320.
   PubMed Web of Science ®Google Scholar
• Seger, R., and J. Krebs 1995. The MAPK signaling cascade. FASEB J. 9:726–735.
   PubMed Web of Science ®Google Scholar
• Tapon, N., and J. Hall 1997. Rho, Rac and Cdc42 GTPases regulate the organization of the actin cytoskeleton. Curr. Opin. Cell Biol. 9:86–92.
   PubMed Web of Science ®Google Scholar
• Teramoto, H., P. Crespo, O. A. Coso, T. Igishi, N. Xu, and J. Gutkind 1996. The small GTP-binding protein rho activates c-Jun N-terminal kinases/stress-activated protein kinases in human kidney 293T cells. Evidence for a Pak-independent signaling pathway. J. Biol. Chem. 271:25731–25734.
   PubMedGoogle Scholar
• Trudel, M., V. D’Agati, and J. Constantini 1991. C-myc as an inducer of polycystic kidney disease in transgenic mice. Kidney Int. 39:665–671.
   PubMed Web of Science ®Google Scholar
• Trudel, M., J. Lanoix, L. Barisoni, M. J. Blouin, M. Desforges, C. L’Italien, and J. D’Agati 1997. C-myc-induced apoptosis in polycystic kidney disease is Bcl-2 and p53 independent. J. Exp. Med. 186:1873–1884.
   PubMed Web of Science ®Google Scholar
• Tsiokas, L., E. Kim, T. Arnould, V. P. Sukhatme, and J. Walz 1997. Homo- and heterodimeric interactions between the gene products of PKD1 and PKD2. Proc. Natl. Acad. Sci. USA 94:6965–6970.
   PubMed Web of Science ®Google Scholar
• Wesselborg, S., M. K. A. Bauer, M. Vogt, M. L. Schmitz, and J. Schulze-Osthoff 1997. Activation of transcription factor NF-kappaB and p38 mitogen-activated protein kinase is mediated by distinct and separate stress effector pathways. J. Biol. Chem. 272:12422–12429.
   PubMed Web of Science ®Google Scholar
• Wu, G., V. D’Agati, Y. Cai, G. Markowitz, J. H. Park, D. M. Reynolds, Y. Maeda, T. C. Le, H. Hou Jr., R. Kucherlapati, W. Edelmann, and J. Somlo 1998. Somatic inactivation of Pkd2 results in polycystic kidney disease. Cell 93:177–188.
   PubMed Web of Science ®Google Scholar
• Zhang, S., J. Han, M. A. Sells, J. Chernoff, U. G. Knaus, R. J. Ulevitch, and J. Bokoch 1995. Rho family GTPases regulate p38 mitogen-activated protein kinase through the downstream mediator Pak1. J. Biol. Chem. 270:23934–23936.
   PubMed Web of Science ®Google Scholar